LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an route of administration.
Function
Effects similar to anabolics with size and strength
Minimal Side Effects2 Excellent for recomping
Healing properties4 Prevents muscle wasting
Works well as a stand alone or stacked with other SARMS